Results 91 to 100 of about 31,086 (166)

Construction of a nomogram model for predicting benignity and malignancy in adnexal masses. [PDF]

Ultrasonography
Zhang K, Wen L, Guo Y, Zhou S, Fu Y, Huang Y, Zhao B.   +6 more
europepmc   +1 more source

From Tumor Marker to Congestion Indicator: The Expanding Role of CA-125 in Heart Failure and Beyond. [PDF]

Health Sci Rep
Almasi MH, Salehi SA, Ebrahimi A, Heidaresfahani L, Nassiri A.   +4 more
europepmc   +1 more source

Interleukin-6 and hormonal biomarker profiles in Moroccan women with endometriosis. [PDF]

Obstet Gynecol Sci
Nadifi C, Hilali C, Mbaye MM, Zarqaoui M, Louanjli N, Benkhalifa M, Lahlou FA.   +6 more
europepmc   +1 more source

Expression of CA125 in adenomyosis

Polish Journal of Pathology, 1995
Goluda, Marian, Ujec, Mieczysław
openaire  

Impact of cancer outcome data source on the diagnostic accuracy of ovarian cancer prediction models: a primary care cohort study. [PDF]

BMJ Public Health
Yu YT, Walter FM, Arendse KD, Funston G.
europepmc   +1 more source

Antygen CA125

Postępy Higieny i Medycyny Doświadczalnej, 2002
openaire  

Peritoneal Lymphomatosis Mimicking Advanced Ovarian Malignancy: A Diagnostic Challenge in Diffuse Large B-Cell Lymphoma. [PDF]

Cureus
Kyeremateng D, Umelue L, Black M, Ndlovu C.   +3 more
europepmc   +1 more source

The Role of Mesothelin in Gynecological Tumors and Its Significance in Targeted Therapies-A Review. [PDF]

Cancers (Basel)
Kawecka W, Wilczyński JR, Tyczyńska M, Bielak M, Obrzut B, Semczuk A.   +5 more
europepmc   +1 more source

Cancer antigen 125 levels change rule after laparoscopic biopsy and its prognostic value for patients with unresectable pancreatic ductal adenocarcinoma: a retrospective preliminary exploratory study. [PDF]

BMC Gastroenterol
Wu Y, Luo X, Chen C, Lin X, Lin R, Wang C, Huang H, Lu F.   +7 more
europepmc   +1 more source